M3-Brigade Acquisition V Corp. $MBAV Shares Purchased by Saba Capital Management L.P.

Saba Capital Management L.P. boosted its position in shares of M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) by 11,039.2% during the first quarter, Holdings Channel reports. The firm owned 1,585,000 shares of the company’s stock after buying an additional 1,570,771 shares during the quarter. Saba Capital Management L.P.’s holdings in M3-Brigade Acquisition V were worth $17,023,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of MBAV. Cantor Fitzgerald L. P. increased its position in shares of M3-Brigade Acquisition V by 4,940.8% in the fourth quarter. Cantor Fitzgerald L. P. now owns 7,779,865 shares of the company’s stock valued at $82,700,000 after buying an additional 7,625,527 shares in the last quarter. Anson Funds Management LP purchased a new stake in shares of M3-Brigade Acquisition V in the 4th quarter worth about $30,193,000. Meteora Capital LLC boosted its position in shares of M3-Brigade Acquisition V by 163.5% in the 4th quarter. Meteora Capital LLC now owns 3,889,052 shares of the company’s stock worth $41,341,000 after buying an additional 2,413,251 shares in the last quarter. Polar Asset Management Partners Inc. grew its stake in M3-Brigade Acquisition V by 117.0% in the 1st quarter. Polar Asset Management Partners Inc. now owns 3,812,849 shares of the company’s stock valued at $40,950,000 after acquiring an additional 2,055,408 shares during the last quarter. Finally, Pantera Capital Partners LP acquired a new stake in M3-Brigade Acquisition V in the 3rd quarter valued at about $15,825,000.

M3-Brigade Acquisition V Stock Performance

NASDAQ:MBAV opened at $11.29 on Tuesday. M3-Brigade Acquisition V Corp. has a 12-month low of $9.10 and a 12-month high of $11.96. The company’s 50-day moving average is $10.84 and its two-hundred day moving average is $10.77.

M3-Brigade Acquisition V (NASDAQ:MBAV) last issued its quarterly earnings results on Thursday, May 14th. The company reported $0.05 EPS for the quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on MBAV shares. Wall Street Zen upgraded shares of M3-Brigade Acquisition V to a “sell” rating in a research report on Saturday, June 27th. Weiss Ratings reissued a “sell (d)” rating on shares of M3-Brigade Acquisition V in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, M3-Brigade Acquisition V has a consensus rating of “Sell”.

M3-Brigade Acquisition V Profile

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.